ATE124950T1 - Nucleosid-analoge. - Google Patents
Nucleosid-analoge.Info
- Publication number
- ATE124950T1 ATE124950T1 AT88905320T AT88905320T ATE124950T1 AT E124950 T1 ATE124950 T1 AT E124950T1 AT 88905320 T AT88905320 T AT 88905320T AT 88905320 T AT88905320 T AT 88905320T AT E124950 T1 ATE124950 T1 AT E124950T1
- Authority
- AT
- Austria
- Prior art keywords
- nucleoside analogues
- analogues
- retroviral
- ribofuranosyl
- prophylaxis
- Prior art date
Links
- 229940127073 nucleoside analogue Drugs 0.000 title abstract 2
- 206010038997 Retroviral infections Diseases 0.000 abstract 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 230000001177 retroviral effect Effects 0.000 abstract 1
- 238000010839 reverse transcription Methods 0.000 abstract 1
- 125000000548 ribosyl group Chemical group C1([C@H](O)[C@H](O)[C@H](O1)CO)* 0.000 abstract 1
- 238000011282 treatment Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/06—Pyrimidine radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US5830487A | 1987-06-05 | 1987-06-05 | |
| US19027388A | 1988-05-04 | 1988-05-04 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE124950T1 true ATE124950T1 (de) | 1995-07-15 |
Family
ID=26737474
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT88905320T ATE124950T1 (de) | 1987-06-05 | 1988-05-26 | Nucleosid-analoge. |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP0365556B1 (de) |
| AT (1) | ATE124950T1 (de) |
| DE (1) | DE3854158T2 (de) |
| WO (1) | WO1988009796A1 (de) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0538194B1 (de) * | 1991-10-17 | 1997-06-04 | Novartis AG | Bicyclische Nukleoside, Oligonukleotide, Verfahren zu deren Herstellung und Zwischenprodukte |
| US6872827B2 (en) | 2002-04-26 | 2005-03-29 | Chembridge Research Laboratories, Inc. | Somatostatin analogue compounds |
| EP3763724A4 (de) * | 2018-03-09 | 2022-01-12 | Japan Science and Technology Agency | Ss-modifizierter phosphorsäureverbindungsvorläufer, ss-modifizierte phosphorsäureverbindung, reaktionsinhibitor und medikament damit sowie reaktionshemmungsverfahren |
-
1988
- 1988-05-26 EP EP88905320A patent/EP0365556B1/de not_active Expired - Lifetime
- 1988-05-26 AT AT88905320T patent/ATE124950T1/de not_active IP Right Cessation
- 1988-05-26 WO PCT/US1988/001812 patent/WO1988009796A1/en not_active Ceased
- 1988-05-26 DE DE3854158T patent/DE3854158T2/de not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| DE3854158D1 (de) | 1995-08-17 |
| WO1988009796A1 (en) | 1988-12-15 |
| EP0365556A1 (de) | 1990-05-02 |
| DE3854158T2 (de) | 1996-01-18 |
| EP0365556B1 (de) | 1995-07-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK224286A (da) | 2',3'-dideoxy-nucleosider | |
| CY1889A (en) | Use of 3'-azido-3'-deoxythymidine in the treatment or prophylaxis of human retroviral infections | |
| MY103388A (en) | Azithromycin and derivatives as antiprotozoal agents | |
| DK0574457T3 (da) | Antiviral nucleosidkombination | |
| GB2204237B (en) | Agents for the prophylaxis and therapy of retroviral infections | |
| ES509706A0 (es) | "mejoras introducidas en el objeto de la patente principal n 504.302". | |
| DK441786D0 (da) | Nucleosider, der kan anvendes terapeutisk | |
| IT1224594B (it) | Impiego in terapeutica di derivati del 4h-benzo-4,5-cicloepta-1,2-bqti ofene | |
| ATE100098T1 (de) | Nukleoside, ihre herstellung und pharmazeutische zusammenstellungen. | |
| FI863971A7 (fi) | Farmaseuttinen koostumus käytettäväksi leukopenian hoidossa. | |
| DK18488D0 (da) | Synergistisk kombination af azelastin og theophyllin eller azelastin og beta-mimetika | |
| IT1217446B (it) | Composizione oftalmologica | |
| GB8822546D0 (en) | Antiviral combinations | |
| ATE124950T1 (de) | Nucleosid-analoge. | |
| BR8805426A (pt) | Composicao de organopolissiloxano e utilizacao da mesma | |
| IT8621111A0 (it) | Composizioni per il trattamento del le sindromi da ischemia e riperfusione | |
| NO894658D0 (no) | Antivirale forbindelser. | |
| DE3879709D1 (de) | Platin-arzneimittel. | |
| IT1102304B (it) | Composizione farmaceutica per la cura della sordita' e del ronzio auricolare | |
| IT1184687B (it) | Derivato del piridone dotato di procprieta' cardiotoniche e composizioni farmaceutiche contenenti detto derivato | |
| IT1218850B (it) | Procedimento per la preaparazione di biossido di benzotiazina farmaceuticamente utilizzabile e intermedio da usare nel procedimento | |
| RO94487A2 (ro) | Compozitie pentru fabricarea frinelor cu tambur utilizate la autovehiculele grele | |
| IT8667884A0 (it) | Procedimento per la purificazione del linuron | |
| GB8711424D0 (en) | Prophylaxis & treatment of retroviral infections |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| EELA | Cancelled due to lapse of time |